Evogene Reports Second Quarter of 2019 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/24/2026

1. DECK
2. RNG
3. WDC
4. BYD
5. SPOT
6. WCN
7. BMY
8. FIX
9. TSCO
10. BE

Go back to Evogene Reports Second Quarter of 2019 Financial Results

Evogene (EVGN) Reports Q2 Loss of $0.31, Revenues Miss

July 31, 2019 7:22 AM EDT

Evogene (NASDAQ: EVGN) reported Q2 EPS of ($0.31), versus ($0.39) reported last year. Revenue for the quarter came in at $540 thousand versus the consensus estimate of $1.9 million.

Revenues primarily consist of research and development payments. These revenues represent R&D cost reimbursement and milestone payments under our various collaboration agreements. The majority of these agreements also provide for royalties or other forms of revenue sharing from successfully developed products.Gross profit for the first half of 2019 was approximately $0.4 million in comparison to approximately $0.2 million for the first half of 2018. Gross profit for the second... More